STEPHANIE BAILEY: Open Payments
NPI 1003440447 · BLAIRSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 22 payments from 11 companies in 2025. Trend: 2023 $103 · 2024 $490 · 2025 $465
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $157 |
| Merck Sharp & Dohme LLC | 4 | $77 |
| Edwards Lifesciences Corporation | 2 | $67 |
| SCPHARMACEUTICALS INC. | 2 | $32 |
| Boston Scientific Corporation | 1 | $29 |
| Abbott Laboratories | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
| PFIZER INC. | 1 | $15 |
Products named: LEQVIO, SAPIEN 3 Ultra RESILIA, VERQUVO, FUROSCIX, WATCHMAN FLX, CARDIOMEMS, JARDIANCE, OPSUMIT.
Industry payments across GA — which companies pay providers there.
